Evogene (EVGN) Retained Earnings (2016 - 2025)

Evogene (EVGN) has disclosed Retained Earnings for 9 consecutive years, with -$282.6 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 3.1% to -$282.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$282.6 million through Dec 2025, down 3.1% year-over-year, with the annual reading at -$282.6 million for FY2025, 3.1% down from the prior year.
  • Retained Earnings hit -$282.6 million in Q4 2025 for Evogene, down from -$274.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$207.1 million in Q4 2021 to a low of -$282.6 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$251.0 million across 5 years, with a median of -$257.6 million in 2023.
  • Biggest five-year swings in Retained Earnings: dropped 15.5% in 2021 and later decreased 3.1% in 2025.
  • Year by year, Retained Earnings stood at -$207.1 million in 2021, then dropped by 12.86% to -$233.7 million in 2022, then decreased by 10.22% to -$257.6 million in 2023, then decreased by 6.4% to -$274.1 million in 2024, then decreased by 3.1% to -$282.6 million in 2025.
  • Business Quant data shows Retained Earnings for EVGN at -$282.6 million in Q4 2025, -$274.1 million in Q4 2024, and -$257.6 million in Q4 2023.